OpenURL Connection Search

Select item for more details and to access through your institution.

Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative.
Published in:
Diabetes/Metabolism Research & Reviews, 2011, v. 27, n. 8, p. 720, doi. 10.1002/dmrr.1243
By:
- Mallone, R.;
- Scotto, M.;
- Janicki, C. N.;
- James, E. A.;
- Fitzgerald-Miller, L.;
- Wagner, R.;
- Gottlieb, P.;
- Thorpe, J.;
- Jospe, N.;
- Durinovic-Bellò, I.;
- Boitard, C.;
- Lou, O.;
- Dayan, C. M.;
- Wong, F. S.
Publication type:
Article
Reversal of Pathological Features of Graves' Orbitopathy by Activation of Forkhead Transcription Factors, FOXOs.
Published in:
2016
By:
- Zhang, L;
- Ji, Q H;
- Ruge, F;
- Lane, C;
- Morris, D;
- Tee, A R;
- Dayan, C M;
- Ludgate, M
Publication type:
journal article
Possible targets for nonimmunosuppressive therapy of Graves' orbitopathy.
Published in:
2014
By:
- Zhang, L;
- Grennan-Jones, F;
- Draman, M S;
- Lane, C;
- Morris, D;
- Dayan, C M;
- Tee, A R;
- Ludgate, M
Publication type:
journal article
β-cell specific T-lymphocyte response has a distinct inflammatory phenotype in children with Type 1 diabetes compared with adults.
Published in:
Diabetic Medicine, 2017, v. 34, n. 3, p. 419, doi. 10.1111/dme.13153
By:
- Arif, S.;
- Gibson, V. B.;
- Nguyen, V.;
- Bingley, P. J.;
- Todd, J. A.;
- Guy, C.;
- Dunger, D. B.;
- Dayan, C. M.;
- Powrie, J.;
- Lorenc, A.;
- Peakman, M.
Publication type:
Article
Stimulated urine C-peptide creatinine ratio vs serum C-peptide level for monitoring of β-cell function in the first year after diagnosis of Type 1 diabetes.
Published in:
Diabetic Medicine, 2016, v. 33, n. 11, p. 1564, doi. 10.1111/dme.13186
By:
- Tatovic, D.;
- Luzio, S.;
- Dunseath, G.;
- Liu, Y.;
- Alhadj Ali, M.;
- Peakman, M.;
- Dayan, C. M.;
- O'Keefe, A.;
- Stenson, R.;
- Pell, J.;
- Howell, A.;
- Arif, S.;
- Bayly, G.;
- Thorogood, N.;
- Green, K.;
- Andrews, R. C.;
- McLintock, N.;
- Leech, N.;
- Kyne, D.;
- Joseph, F.
Publication type:
Article
Efficacy and safety of low-dose otelixizumab anti- CD3 monoclonal antibody in preserving C-peptide secretion in adolescent type 1 diabetes: DEFEND-2, a randomized, placebo-controlled, double-blind, multi-centre study.
Published in:
Diabetic Medicine, 2014, v. 31, n. 4, p. 399, doi. 10.1111/dme.12361
By:
- Ambery, P.;
- Donner, T. W.;
- Biswas, N.;
- Donaldson, J.;
- Parkin, J.;
- Dayan, C. M.
Publication type:
Article
Sensor-augmented pump therapy lowers HbA1c in suboptimally controlled Type 1 diabetes; a randomized controlled trial.
Published in:
Diabetic Medicine, 2011, v. 28, n. 10, p. 1158, doi. 10.1111/j.1464-5491.2011.03256.x
By:
- Hermanides, J.;
- Nørgaard, K.;
- Bruttomesso, D.;
- Mathieu, C.;
- Frid, A.;
- Dayan, C. M.;
- Diem, P.;
- Fermon, C.;
- Wentholt, I. M. E.;
- Hoekstra, J. B. L.;
- DeVries, J. H.
Publication type:
Article
Magnetic resonance imaging: a reliable method for measuring pancreatic volume in Type 1 diabetes.
Published in:
Diabetic Medicine, 2007, v. 24, n. 1, p. 35, doi. 10.1111/j.1464-5491.2007.02027.x
By:
- Williams, A. J. K.;
- Chau, W.;
- Callaway, M. P.;
- Dayan, C. M.
Publication type:
Article
Reproducibility of individualized coronary heart disease risk calculations in patients with diabetes mellitus.
Published in:
Diabetic Medicine, 2002, v. 19, n. 6, p. 514, doi. 10.1046/j.1464-5491.2002.00687.x
By:
- Lambert, A. P;
- Hunt, M. A;
- Day, A. P;
- Bayly, G. R;
- Dayan, C. M
Publication type:
Article
Acute respiratory distress secondary to Morgagni diaphragmatic herniation in an adult.
Published in:
1995
By:
- Wong, N. A.;
- Dayan, C. M.;
- Virjee, J.;
- Heaton, K. W.
Publication type:
journal article
Announcing the first AoP webinar: 'Can evidence-based medicine survive in a pandemic?'.
Published in:
QJM: An International Journal of Medicine, 2021, v. 114, n. 1, p. 11, doi. 10.1093/qjmed/hcaa287
By:
- Delles, C;
- Dayan, C M;
- Dominiczak, A F;
- Donnelly, S C;
- Irvine, A D
Publication type:
Article
The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy.
Published in:
European Journal of Endocrinology, 2021, v. 185, n. 4, p. G43, doi. 10.1530/EJE-21-0479
By:
- Bartalena, L.;
- Kahaly, G. J.;
- Baldeschi, L.;
- Dayan, C. M.;
- Eckstein, A.;
- Marcocci, C.;
- Marinò, M.;
- Vaidya, B.;
- Wiersinga, W. M.
Publication type:
Article
Activated T cell subsets in human type 1 diabetes: evidence for expansion of the DR+ CD30+ subpopulation in new-onset disease.
Published in:
Clinical & Experimental Immunology, 2007, v. 147, n. 3, p. 472, doi. 10.1111/j.1365-2249.2006.03307.x
By:
- Baker, C.;
- Chang, L.;
- Elsegood, K. A.;
- Bishop, A. J.;
- Gannon, D. H.;
- Narendran, P.;
- Leech, N. J.;
- Dayan, C. M.
Publication type:
Article
Thyroxine replacement: a clinical endocrinologist's viewpoint.
Published in:
2016
By:
- Eligar, V.;
- Taylor, P. N.;
- Okosieme, O. E.;
- Leese, G. P.;
- Dayan, C. M.
Publication type:
journal article
Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study.
Published in:
Clinical & Experimental Immunology, 2009, v. 155, n. 2, p. 156, doi. 10.1111/j.1365-2249.2008.03814.x
By:
- Thrower, S. L.;
- James, L.;
- Hall, W.;
- Green, K. M.;
- Arif, S.;
- Allen, J. S.;
- Van-Krinks, C.;
- Lozanoska-Ochser, B.;
- Marquesini, L.;
- Brown, S.;
- Wong, F. S.;
- Dayan, C. M.;
- Peakman, M.
Publication type:
Article
Preparing for first-in-man studies: the challenges for translational immunology post-TGN1412.
Published in:
Clinical & Experimental Immunology, 2008, v. 151, n. 2, p. 231, doi. 10.1111/j.1365-2249.2007.03559.x
By:
- Dayan, C. M.;
- Wraith, D. C.
Publication type:
Article
Effective formation of major histocompatibility complex class II–peptide complexes from endogenous antigen by thyroid epithelial cells.
Published in:
Immunology, 2000, v. 99, n. 3, p. 367, doi. 10.1046/j.1365-2567.2000.00958.x
By:
- Maile, R.;
- Elsegood, K. A.;
- Harding, T. C.;
- Uney, J. B.;
- Stewart, C. E. H.;
- Banting, G.;
- Dayan, C. M.
Publication type:
Article
Orbital decompression for Graves' orbitopathy in England.
Published in:
Eye, 2012, v. 26, n. 3, p. 434, doi. 10.1038/eye.2011.323
By:
- Perros, P;
- Chandler, T;
- Dayan, C M;
- Dickinson, A J;
- Foley, P;
- Hickey, J;
- MacEwen, C J;
- Lazarus, J H;
- McLaren, J;
- Rose, G E;
- Uddin, J M;
- Vaidya, B
Publication type:
Article
Immunotherapy for type 1 diabetes.
Published in:
British Medical Bulletin, 2021, v. 140, n. 1, p. 76, doi. 10.1093/bmb/ldab027
By:
- Allen, L A;
- Dayan, C M
Publication type:
Article
Marian Ludgate—the scientist and her festschrift.
Published in:
2020
By:
- Dayan, C. M.;
- Premawardhana, L. D.
Publication type:
Editorial
Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2006, v. 23, n. 10, p. 1435, doi. 10.1111/j.1365-2036.2006.02904.x
By:
- CREED, T. J.;
- PROBERT, C. S. J.;
- NORMAN, M. N.;
- MOORGHEN, M.;
- SHEPHERD, N. A.;
- HEARING, S. D.;
- DAYAN, C. M.
Publication type:
Article
Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2003, v. 18, n. 1, p. 65, doi. 10.1046/j.1365-2036.2003.01639.x
By:
- Creed, T. J.;
- Norman, M. R.;
- Probert, C. S. J.;
- Harvey, R. F.;
- Shaw, I. S.;
- Smithson, J.;
- Anderson, J.;
- Moorghen, M.;
- Gupta, J.;
- Shepherd, N. A.;
- Dayan, C. M.;
- Hearing, S. D.
Publication type:
Article
Thyroid function and the natural history of depression: findings from the Caerphilly Prospective Study (CaPS) and a meta-analysis.
Published in:
Clinical Endocrinology, 2009, v. 70, n. 3, p. 484, doi. 10.1111/j.1365-2265.2008.03352.x
By:
- Williams, M. D.;
- Harris, R.;
- Dayan, C. M.;
- Evans, J.;
- Gallacher, J;
- Ben-Shlomo, Y.
Publication type:
Article
Psychological well-being in patients on ‘adequate’ doses of l-thyroxine: results of a large, controlled community-based questionnaire study.
Published in:
Clinical Endocrinology, 2002, v. 57, n. 5, p. 577, doi. 10.1046/j.1365-2265.2002.01654.x
By:
- Saravanan, P.;
- Chau, W.-F.;
- Roberts, N.;
- Vedhara, K.;
- Greenwood, R.;
- Dayan, C. M.
Publication type:
Article

Found: 24

Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative.

Reversal of Pathological Features of Graves' Orbitopathy by Activation of Forkhead Transcription Factors, FOXOs.

Possible targets for nonimmunosuppressive therapy of Graves' orbitopathy.

β-cell specific T-lymphocyte response has a distinct inflammatory phenotype in children with Type 1 diabetes compared with adults.

Stimulated urine C-peptide creatinine ratio vs serum C-peptide level for monitoring of β-cell function in the first year after diagnosis of Type 1 diabetes.

Efficacy and safety of low-dose otelixizumab anti- CD3 monoclonal antibody in preserving C-peptide secretion in adolescent type 1 diabetes: DEFEND-2, a randomized, placebo-controlled, double-blind, multi-centre study.

Sensor-augmented pump therapy lowers HbA<sub>1c</sub> in suboptimally controlled Type 1 diabetes; a randomized controlled trial.

Magnetic resonance imaging: a reliable method for measuring pancreatic volume in Type 1 diabetes.

Reproducibility of individualized coronary heart disease risk calculations in patients with diabetes mellitus.

Acute respiratory distress secondary to Morgagni diaphragmatic herniation in an adult.

Announcing the first AoP webinar: 'Can evidence-based medicine survive in a pandemic?'.

The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy.

Activated T cell subsets in human type 1 diabetes: evidence for expansion of the DR<sup>+</sup> CD30<sup>+</sup> subpopulation in new-onset disease.

Thyroxine replacement: a clinical endocrinologist's viewpoint.

Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study.

Preparing for first-in-man studies: the challenges for translational immunology post-TGN1412.

Effective formation of major histocompatibility complex class II–peptide complexes from endogenous antigen by thyroid epithelial cells.

Orbital decompression for Graves' orbitopathy in England.

Immunotherapy for type 1 diabetes.

Marian Ludgate—the scientist and her festschrift.

Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease.

Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.

Thyroid function and the natural history of depression: findings from the Caerphilly Prospective Study (CaPS) and a meta-analysis.

Psychological well-being in patients on ‘adequate’ doses of l-thyroxine: results of a large, controlled community-based questionnaire study.